Designing Accessible Pharmaceutical Packaging: Integrating Diversity, Equity, and Inclusion for Patient-Centered Care

In an increasingly complex regulatory environment, businesses must navigate global compliance while integrating sustainability mandates. This session explores strategies for aligning with evolving regulations and regional variations, ensuring businesses remain compliant, competitive, and sustainable. Attendees who want to stay ahead of international regulatory changes should join this session to gain insights into integrating sustainability into regulatory planning.

The landscape of clinical trials is undergoing a transformative shift as digital technologies continue to permeate every aspect of the healthcare industry. One potential transformation could be the replacement of traditional paper-based relabeling in clinical trials with digital display labels. The integration of digital display labels into clinical trials represents a significant leap forward in the industry. As this technology matures and becomes more widely adopted, it could impact the way clinical trials are conducted and managed especially in the areas of remote monitoring, adaptive trials, and patient engagement. In this session, we will explore the challenges associated with traditional relabeling processes in clinical trials, the advantages of adopting digital display labels, and the potential impact on the future of healthcare research.

Join us for a dynamic panel where we explore how diverse new ideas and fresh initiatives are shaping a more sustainable world. Through discussions on collaborative competition, pioneering ventures, and new perspectives, we'll uncover the innovative approaches driving sustainability across industries. This session offers a unique opportunity to understand the intersections of business, innovation, and collaboration in building a greener future.

This session will explore the latest trends and growing complexities in parenteral drug packaging and labelling. Lars Skole will address challenges such as the rise of new medicines, self-administered treatments, international market demands, and price pressures, offering insights into how pharmaceutical developers and manufacturers can adapt. Key Topics: Growing need for small-batch production to meet the demand for personalized medicine, faster time to market, and global distribution. Enhancing efficiency and flexibility through quicker changeovers. Leveraging digitalization and cutting-edge technologies like advanced robotics, contactless transportation, digital twins, IoT, and in-line printing to drive innovation and improve operations.

This session focuses on practical strategies for becoming a more sustainable exhibitor, offering insights into how Informa’s Better Stands programme is transforming the events industry. Participants will learn how to reduce environmental impact through smarter, more sustainable approaches to exhibition stand design. Through the lens of the programme’s success at CPHI and Pharmapack, the session will showcase real-world examples and actionable steps for adopting sustainable practices. Attendees will gain valuable tips for planning greener events, engaging with exhibitors, contractors, and stakeholders to make a positive impact.

Contract Packaging Organizations (CPOs) and Contract Development and Manufacturing Organizations (CDMOs) play critical roles in the pharmaceutical supply chain. Their strategic visions are shaped by evolving industry demands, technological advancements, and regulatory requirements. This panel will highlight key industry stakeholders’ strategic visions.

With growing pressure to reduce emissions, a collaborative approach is essential. This workshop will explore innovative strategies to transform value chains. This 75-min session will demonstrate how to build sustainable supply chains based on experience out of the Alliance to Zero’s work and via interactive workshop elements. The Alliance to Zero is a supply chain collaboration founded to facilitate the transitioning of injection devices to net-zero. With for instance its concept for secure blisterfree syringe packaging it has successfully proven the power of co-innovation from an ecosystem perspective: across its members they solved a supply challenge beyond their business scope and generated value for multiple stakeholders up to users. Participants will leave the session with valuable insights and hand-on learning of the value chain approach that will help shape the sustainable future of pharma.

Traditional procurement, centered on cost-cutting and risk management, is no longer sufficient in today’s interconnected and rapidly changing world. Modern procurement must tackle broader and more complex challenges to remain effective and relevant. Regenerative Procurement offers a proactive, holistic framework that transcends sustainability by delivering net-positive impacts on the environment, society, and business operations. Rather than simply maintaining the status quo, it focuses on enhancing the entire procurement ecosystem. This approach fuels innovation, drives top-line growth, and supports the triple bottom line—People, Planet, and Profit. It boosts financial performance, strengthens supplier relationships, and generates long-term societal and environmental benefits that go beyond immediate business objectives. By addressing global challenges like economic volatility, social pressures, environmental crises, technological disruptions, and geopolitical uncertainties, Regenerative Procurement redefines procurement as a key enabler of both business success and sustainable transformation.

Late differentiation solutions have become a cornerstone of outsourcing strategies, addressing critical challenges such as flexibility, regulatory compliance, and cost and material optimization. This keynote will explore how innovative packaging technologies, such as shrink sleeve labels, meet these demands with precision and efficiency. Drawing on real-world business cases developed by Sleever and their partners in the cosmetics and pharmaceutical sectors, this session will demonstrate how solutions initially designed for cosmetics can be seamlessly transferred to meet the stringent requirements of the pharmaceutical industry.

The journey from the clinic to the market and the importance of the pharmaceutical supply chain Are CPOs and CDMOs aligned? Print vs digital labeling – both? One or the other? Cost considerations in small batch manufacturing, labelling, and packaging. At what point do I need to worry about trackability and traceability? Speed to market: does vertical integration ensure bringing innovative products to the market more efficiently

Informa collaborates with the industry's leading sustainability associations to forge the Pharmaceutical future and support sustainable practices. Be the first to hear about groundbreaking initiatives and the latest news on these new partnerships, set to revolutionize the industry at the next Pharmapack Edition. Join us to explore collaborative efforts and the exciting journey towards a greener, more sustainable future in Pharma Packaging and Drug Delivery.

Packaging is a key factor in the production, commercialization, distribution, and proper preservation of pharmaceutical products. Flexible packaging has always been a good alternative because, by combining different materials, we can create unique packaging that unifies the best properties of each material. However, the industry is currently facing challenges in advancing the recyclability of packaging. In this session, we will discuss conventional structures and explore alternatives to ensure the correct recyclability of packaging without compromising the proper preservation of the product.

Often, sustainability and efficiency are hindered by the perception that other actors in the supply chain are not fulfilling their roles effectively. This panel will bring together key stakeholders from across the entire pharmaceutical supply chain. Participants will engage in an honest dialogue, sharing their concerns and brainstorming collaborative solutions. The goal is to foster mutual understanding and identify strategies that can drive positive sustainable outcomes for the industry as a whole as well as a resilience supply chain.

This session will begin with an introduction to Informa's Sustainability Partner, Adelphe, offering an overview of the organization and its mission. Experts will discuss what defines recyclable packaging, the current recycling pathways, and what can be expected in the future. Additionally, the speakers will explore how chemical recycling can contribute to providing recycled materials for sensitive applications, such as pharmaceutical packaging.

Discover how Novo Nordisk is driving environmental innovation with its Circular for Zero strategy, which aims for zero environmental impact. This session delves into Novo Nordisk’s proactive approach to tackling plastic waste by focusing on reducing, changing, and avoiding plastic use from product design and development to End-of-Life. Attendees will learn how Design for Circularity principles are embedded in device projects to minimize environmental impact across the product lifecycle. The session will also explore the pharmaceutical sector’s broader shift toward a circular economy, underscoring the essential role of partnerships and collaborations in driving sustainable, industry-wide transformation.

The presentation addresses the challenges of transitioning from traditional to sustainable blister packaging. While taking a closer look at thermoforming processes, barrier properties, drug stability and push-through force in pharmaceutical packaging, we will explore how scientific services can support the transition to sustainable blister packaging while ensuring a successful conversion, compliance with regulatory standards, and enhanced patient safety.

Global markets are increasingly penalizing linear business models that harm the environment and society, making a strong case for sustainable practices. In pharmaceutical packaging, this shift demands rethinking strategies to maximize resource efficiency while protecting human and planetary health. As packaging systems evolve in response to consumer preferences and regulatory pressures, businesses must recognize that the costs of inaction far outweigh the investments needed to adapt. Those leading sustainability initiatives must craft compelling narratives for leadership, highlighting how sustainable practices can turn perceived costs into long-term investments with tangible returns. Drawing on our extensive experience working globally with the pharmaceutical sector and healthcare brands, Anthesis will frame these challenges, and demonstrate that by looking at solutions differently, pharmaceutical organisations can create a business case for success.

Pharma is guilty of gender disparity across its workforce and has historically been male dominated. Part of the problem could be that when it comes to roles in STEM, there still exists an ‘implicit bias’. How can we address the unconscious bias associated with the healthcare industry, and pave the way for more female leaders in pharma?

Per- and polyfluoroalkyl substances (PFAS) have long been integral in pharmaceutical packaging due to their unique properties. However, emerging regulatory changes in both the United States and the European Union have signaled a pivotal shift in the use of PFAS materials, particularly in pharmaceutical packaging. This 35-minute speech will delve into the implications these new regulations pose for the pharmaceutical industry and explore the differences in approaches between US and EU authorities. The discussion will commence with an overview of PFAS materials and their historical significance in pharmaceutical packaging, elucidating the reasons behind their prevalent use. Emphasis will be placed on the unique characteristics of PFAS, ensuring the safety and efficacy of pharmaceutical products. Subsequently, the speech will scrutinize the recent regulatory landscape in both the US and the EU. The contrasting approaches adopted by the respective authorities regarding PFAS regulation will be highlighted, encompassing the restrictions, bans, permissible limits, and timeline for implementation. This comparative analysis aims to elucidate the divergent strategies and their potential impact on the pharmaceutical packaging industry in each region. Furthermore, the speech will explore the challenges and opportunities arising from these regulatory changes. It will address the implications for pharmaceutical companies, including the necessity for alternative packaging materials, compliance strategies, potential economic ramifications, and the quest for sustainable alternatives that maintain product safety and efficacy. Moreover, the audience will gain insights into the technological advancements and innovative solutions emerging in response to these regulations. The discussion will touch upon ongoing research and development efforts aimed at creating PFAS-free packaging options without compromising pharmaceutical product integrity. In conclusion, the speech will underscore the importance of proactive adaptation and collaboration between stakeholders in the pharmaceutical industry to navigate the changing regulatory landscape. It will advocate for a concerted effort to foster sustainable practices and drive innovation in packaging materials while ensuring the highest standards of product safety and compliance with evolving regulations in both the US and the EU.

Sophrology is a modern and dynamic meditation practice which helps you tackle the challenges of today's world. This practice blends breathing exercises, gentle movement and positive visualization to help you de-stress your body, rewire your brain, transform the way you feel and unlock your full potential. Close your eyes and let your body show you the way to let go of your worries and open your mind to new perspectives. Transform blockages negativity into resilience and confidence. After this session you will feel more balanced and ready to perform at your best. Be your true self: aligned with your values and ready to embrace everything life has to offer. All over Europe millions of people have already experienced the transformational power of sophrology, now it's your turn to see what it can do for you. Let's discover some of these simple exercises.

Major players in the pharmaceutical supply chain are increasingly looking towards CPOs to outsource an essential step of drug production and distribution, but what are the opportunities and challenges to consider before moving forward?

From unconscious bias to the gender pay gap, and lack of women in leadership roles – gender disparity continues to be a very real challenge faced by pharma. This panel will gather leaders from across the pharma packaging landscape to share their experiences of tackling inequality in the workplace, and to share strategies on creating a more level playing field for the female workforce of the future.